Some white blood cells, appropriately called killer T cells, can kill cancer cells. Unfortunately, cancers can evolve resistance to killer T cell attack by exploiting natural 'immune checkpoints'. The author explains how exciting new medicines can block these checkpoints, freeing killer T cells to kill cancers.